Comparison of Alemtuzumab Versus Basiliximab Induction Therapy in Elderly Kidney Transplant Recipients: A Single-Center Experience.
Idris YakubuBharath RavichandranTracy SparkesRolf N BarthAbdolreza HaririanBrian MastersPublished in: Journal of pharmacy practice (2019)
Alemtuzumab induction is associated with similar outcomes to basiliximab in elderly kidney transplant recipients.